UBS Group’s Chimera Investment CIM Stock Holding History

UBS Group’s Portfolio CIM Stock Details CIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-125,500	Closed	-$1.76M	–	10273
2024 Q4	$1.76M	Hold	125,500	–	–	﹤0.01%	4843
2024 Q3	$1.99M	Buy	125,500 +100,000	+392%	+$1.5M	﹤0.01%	3996
2024 Q2	$326K	Buy	+25,500	New	+$323K	﹤0.01%	5320
2020 Q1	–	Sell	-337,667	Closed	-$20.8M	–	7999
2019 Q4	$20.8M	Buy	+337,667	New	+$20.6M	0.01%	1345
2017 Q1	–	Sell	-177,333	Closed	-$9.05M	–	7670
2016 Q4	$9.05M	Buy	+177,333	New	+$8.69M	0.01%	1582
2015 Q1	–	Sell	-5,120	Closed	-$244K	–	8870
2014 Q4	$244K	Buy	+5,120	New	+$247K	﹤0.01%	4844

Other funds holding CIM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

UBS Group's CIM Position: Q2 2026 in Review

UBS Group reduced its Chimera Investment (CIM) stake by 7.7% in Q2 2026, selling an estimated $491K and leaving 440,890 shares worth $5.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3992.

UBS Group first reported a position in CIM in Q4 2014 and has held it in 47 quarters since. The position peaked at $57.3M in Q3 2019. 197 funds tracked by Wall St. Rank hold CIM as of Q2 2026.

UBS Group held 440,890 shares of Chimera Investment worth $5.88M as of Q2 2026.
UBS Group sold 36,709 Chimera Investment shares in Q2 2026, an estimated $491K.
Chimera Investment made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3992 holding.
UBS Group first reported a position in Chimera Investment in Q4 2014 and has held it in 47 quarters since.
UBS Group's Chimera Investment position peaked at $57.3M in Q3 2019.
197 funds tracked by Wall St. Rank held Chimera Investment as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.